News | 13 October 2026
Briefs: Sun Pharma, Jubilant Pharmova and Fortis Healthcare
Sun Pharma Board approves Rs. 10,000 crore NCD issuance
Sun Pharma Board approves Rs. 10,000 crore NCD issuance
The aim is to address the unique health challenges faced by Armed Forces personnel and civilians living in the Himalayan belt
The expansion adds local production of Aptar’s pressurized metered dose inhaler (pMDI) valves, breath-actuated systems and multi dose nasal spray systems
The Armenian Ministry of Health granted separate marketing authorizations for the two medicines
Ono will secure exclusive rights to develop and commercialize Biohaven’s MoDE pan-IgG degrader portfolio in Japan, South Korea, Taiwan and the Association of Southeast Asian Nations (ASEAN) region
The randomized, double-blind, placebo-controlled trial included 233 evaluable patients across 11 US cancer centers
Most current LVV manufacturing approaches rely on multi-plasmid transient transfection
The business continues to see very strong demand for the RUBY-FILL
The water-soluble polymer provides drugmakers with a plant-based alternative to synthetic excipients
The country’s population aged 60 years and above is projected to rise from around 153 million in 2022 to approximately 347 million by 2050
His remarks underscored the need to strengthen India's capabilities in drug development, biosimilars and pharmaceutical innovation
The launch builds on the established performance of the PanOptix platform
Achieved global milestone with mass graphology campaign for Indian medical fraternity
Rocket is advancing toward important milestones across its cardiovascular pipeline
Cognizant will bring its life sciences and technology expertise to Gilead’s development and operations environment
The facility offers customers an integrated route from early discovery to process development and multi-kilogram cGMP manufacturing
The deal will also broaden Ofichem’s scientific capabilities, adding expertise in polysaccharides, small peptides and complex new chemical entities
The consolidation is expected to give patients across Mumbai and Maharashtra access to a broader range of routine and highly specialised diagnostic services
The Consortium is combining existing industry guidelines with new standards designed to address gaps that have slowed digital adoption
Biodegradable polymer platform builds on Evonik’s seven-decade track record in oral drug delivery
Subscribe To Our Newsletter & Stay Updated
